We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleTargeting HER2-positive cancer with dolastatin 15 derivatives conjugated to trastuzumab, novel antibody-drug conjugates.AuthorsGianolio, Diego; Rouleau, Cecile; Bauta, William; Lovett, Dennis; Cantrell, William; Recio, Antonio; Wolstenholme-Hogg, Paul; Busch, Michelle; Pan, Peng; Stefano, James; Kramer, Hildegard; Goebel, James; Krumbholz, Roy; Roth, Stephanie; Schmid, Steven; Teicher, BeverlyPublicationCancer Chemotherapy & Pharmacology, 2012, Vol 70, Issue 3, p439ISSN0344-5704Publication typearticleDOI10.1007/s00280-012-1925-8